DATE: 4th September 2023 PLACE: Morges, Vaud, Switzerland
SCHEDULE:
OPENING HOURS REGISTRATION
LANGUAGE: 🇬🇧
WORKSHOP VENUE
Hotel La Longeraie Rte de la Longeraie 14 1110 Morges, Switzerland
WORKSHOP STRUCTURE
This is a one-day educational panel featuring worldwide experts for physicians in Switzerland organized by ESRA EUROPE and EHC Hospital in Morges.
The aim is to support the Tara project study protocol, which is financed by the European Commission and the Swiss State Secretariat for Education, Research, and Innovation.
Join this open panel and learn more about this project.
The Tara project is fundamentally based on disrupting the continuum of care and the referral pathway by creating a more effective non-surgical solution. This solution reduces costs and risks, thus increasing accessibility for more physicians and patients.
The consortium will develop a novel platform for treating chronic migraine, which will be particularly applicable in resource-restricted environments and will target underserved patients. We are working on four elements that come together seamlessly:
LUNA-AIR: An implantable electronic device with neural write stimulation.
LUNA-CONTROL: A wearable device that communicates with and powers the implantable device.
LUNA-APP: A mobile app for controlling the implant.
LUNA-INJECT: An ergonomic, minimally invasive injection device that minimizes tissue trauma and required physician training
Eric Buchser
Workshop chair; FMH specialist in anaesthesiology and intensive care at EHC Morges Pain Therapy Policlinic
Sam Eldabe
Chief Scientific Investigator for the clinical study of Tara project 🇨🇭
WORKSHOP TICKETS: Free but very limited space.
Registration by mail to maja.jeremic@esraeurope.org by Augut 30th – places are limited.
RESTRICTION The workshop is restricted to participants from Switzerland.
This workshop was supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 22.00269 and the by the European Union.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.